These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25393963)

  • 1. Cilostazol does not improve peripheral arterial disease-linked oxidative stress.
    Bernal-Lopez MR; Peña D; Gomez-Martin P; Tinahones FJ; Gomez-Huelgas R
    Cardiovasc Ther; 2015 Feb; 33(1):15-9. PubMed ID: 25393963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cilostazol on arterial wound healing: a retrospective analysis.
    Resnick KA; Gordon IL
    Ann Vasc Surg; 2014 Aug; 28(6):1513-21. PubMed ID: 24561209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized pilot trial between prostaglandin I2 analog and anti-platelet drugs on peripheral arterial disease in hemodialysis patients.
    Ohtake T; Sato M; Nakazawa R; Kondoh M; Miyaji T; Moriya H; Hidaka S; Kobayashi S
    Ther Apher Dial; 2014 Feb; 18(1):1-8. PubMed ID: 24499078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cilostazol on oxidative stress, systemic cytokine release, and spinal cord injury in a rat model of transient aortic occlusion.
    Kurtoglu T; Basoglu H; Ozkisacik EA; Cetin NK; Tataroglu C; Yenisey C; Discigil B
    Ann Vasc Surg; 2014 Feb; 28(2):479-88. PubMed ID: 24485778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarpogrelate hydrochloride, a selective 5-HT(2A) receptor antagonist, improves skin perfusion pressure of the lower extremities in hemodialysis patients with peripheral arterial disease.
    Hidaka S; Kobayashi S; Iwagami M; Isshiki R; Tsutsumi D; Mochida Y; Ishioka K; Oka M; Maesato K; Moriya H; Ohtake T
    Ren Fail; 2013; 35(1):43-8. PubMed ID: 23110683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease.
    O'Donnell ME; Badger SA; Sharif MA; Young IS; Lee B; Soong CV
    J Vasc Surg; 2009 May; 49(5):1226-34. PubMed ID: 19217745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Cilostazol Therapy in Hemodialysis Patients with Asymptomatic Peripheral Arterial Disease: A Retrospective Cohort Study.
    Lim PS; Jeng Y; Wu MY; Pai MA; Wu TK; Chen CH
    Biomed Res Int; 2016; 2016():8236903. PubMed ID: 27747241
    [No Abstract]   [Full Text] [Related]  

  • 8. The efficacy and safety of cilostazol in ischemic stroke patients with peripheral arterial disease (SPAD): protocol of a randomized, double-blind, placebo-controlled multicenter trial.
    Jeng JS; Sun Y; Lee JT; Lin RT; Chen CH; Po HL; Lin HJ; Liu CH; Sun MH; Sun MC; Chern CM; Lien LM; Chiu HC; Hu HH; Chiou HY; Chen ST; Ma H; Hsu CY;
    Int J Stroke; 2015 Jan; 10(1):123-7. PubMed ID: 25394855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease.
    Rao AK; Vaidyula VR; Bagga S; Jalagadugula G; Gaughan J; Wilhite DB; Comerota AJ
    Thromb Haemost; 2006 Dec; 96(6):738-43. PubMed ID: 17139367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
    Lee TM; Su SF; Tsai CH; Lee YT; Wang SS
    Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in blood and semen oxidative status in fertile and infertile men, and their relationship with sperm quality.
    Benedetti S; Tagliamonte MC; Catalani S; Primiterra M; Canestrari F; De Stefani S; Palini S; Bulletti C
    Reprod Biomed Online; 2012 Sep; 25(3):300-6. PubMed ID: 22818093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of N-acetylcysteine on skeletal muscle structure and function in a mouse model of peripheral arterial insufficiency.
    Roseguini BT; Silva LM; Polotow TG; Barros MP; Souccar C; Han SW
    J Vasc Surg; 2015 Mar; 61(3):777-86. PubMed ID: 24388697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-Carnitine plus cilostazol versus cilostazol alone for the treatment of claudication in patients with peripheral artery disease: a multicenter, randomized, double-blind, placebo-controlled trial.
    Goldenberg NA; Krantz MJ; Hiatt WR
    Vasc Med; 2012 Jun; 17(3):145-54. PubMed ID: 22615190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cilostazol enhances mobilization and proliferation of endothelial progenitor cells and collateral formation by modifying vasculo-angiogenic biomarkers in peripheral arterial disease.
    Chao TH; Tseng SY; Chen IC; Tsai YS; Huang YY; Liu PY; Ou HY; Li YH; Wu HL; Cho CL; Tsai LM; Chen JH
    Int J Cardiol; 2014 Mar; 172(2):e371-4. PubMed ID: 24439864
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of cilostazol on exercise-induced ischaemia-reperfusion injury in patients with peripheral arterial disease.
    O'Donnell ME; Badger SA; Sharif MA; Makar RR; McEneny J; Young IS; Lee B; Soong CV
    Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):326-35. PubMed ID: 19112032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis.
    Sarban S; Kocyigit A; Yazar M; Isikan UE
    Clin Biochem; 2005 Nov; 38(11):981-6. PubMed ID: 16150434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost.
    Lessiani G; Vazzana N; Cuccurullo C; Di Michele D; Laurora G; Sgrò G; Di Ruscio P; Simeone E; Di Iorio P; Lattanzio S; Liani R; Ferrante E; Davì G
    Thromb Haemost; 2011 Feb; 105(2):321-8. PubMed ID: 21103664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cilostazol treatment on adiponectin and soluble CD40 ligand levels in diabetic patients with peripheral arterial occlusion disease.
    Hsieh CJ; Wang PW
    Circ J; 2009 May; 73(5):948-54. PubMed ID: 19282610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of cilostazol in the treatment of peripheral arterial obstruction.
    Rybak Z
    Pol Arch Med Wewn; 2015; 125(3):117-9. PubMed ID: 25599245
    [No Abstract]   [Full Text] [Related]  

  • 20. Cilostazol decreases total atrial conduction time in patients with peripheral artery disease.
    Alizade E; Sahin M; Simşek Z; Açar G; Bulut M; Güler A; Avcı A; Kalkan ME; Pala S; Akçakoyun M; Esen AM
    Perfusion; 2014 May; 29(3):265-71. PubMed ID: 24280344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.